These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2312765)

  • 1. Steady state pharmacokinetics of propranolol in Saudi Arabian patients and comparison with data for different populations.
    el-Yazigi A; el-Baage T; al-Humaidan A; Yusuf A
    J Clin Pharmacol; 1990 Feb; 30(2):144-50. PubMed ID: 2312765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.
    Lalonde RL; Pieper JA; Straka RJ; Bottorff MB; Mirvis DM
    Eur J Clin Pharmacol; 1987; 33(3):315-8. PubMed ID: 3691620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
    Del Frari L; Léauté-Labrèze C; Guibaud L; Barbarot S; Lacour JP; Chaumont C; Delarue A; Voisard JJ; Brunner V
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00399. PubMed ID: 29736244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
    Wagner JG
    Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol concentrations after oral administration in term and preterm neonates.
    Filippi L; Cavallaro G; Fiorini P; Malvagia S; Della Bona ML; Giocaliere E; Bagnoli P; Dal Monte M; Mosca F; Donzelli G; la Marca G
    J Matern Fetal Neonatal Med; 2013 May; 26(8):833-40. PubMed ID: 23205867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine increases steady state plasma levels of propranolol.
    Reimann IW; Klotz U; Siems B; Frölich J
    Br J Clin Pharmacol; 1981 Dec; 12(6):785-90. PubMed ID: 7340880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state concentrations of amitriptyline and its metabolite nortriptyline in Saudi patients.
    el-Yazigi A; Chaleby K
    Ther Drug Monit; 1987; 9(1):6-10. PubMed ID: 3576661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear pharmacokinetics of unbound propranolol after oral administration.
    Straka RJ; Lalonde RL; Pieper JA; Bottorff MB; Mirvis DM
    J Pharm Sci; 1987 Jul; 76(7):521-4. PubMed ID: 3668812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of azathioprine after repeated oral and single intravenous administration.
    el-Yazigi A; Wahab FA
    J Clin Pharmacol; 1993 Jun; 33(6):522-6. PubMed ID: 8366177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in propranolol pharmacokinetics.
    Johnson JA; Burlew BS
    Clin Pharmacol Ther; 1992 May; 51(5):495-500. PubMed ID: 1587062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.
    Sharoky M; Perkal M; Turner R; Lesko LJ
    Biopharm Drug Dispos; 1988; 9(5):447-56. PubMed ID: 3224162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects.
    Walle T; Walle UK; Cowart TD; Conradi EC
    Clin Pharmacol Ther; 1989 Sep; 46(3):257-63. PubMed ID: 2776391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.
    Feely J; Crooks J; Stevenson IH
    Br J Clin Pharmacol; 1981 Jul; 12(1):73-8. PubMed ID: 6264937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender influence the stereoselective pharmacokinetics of propranolol.
    Gilmore DA; Gal J; Gerber JG; Nies AS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of a new sustained release preparation of propranolol in normal healthy volunteers.
    Biswas NR; Garg SK; Lal R; Kumar N; Gyawali K; Narendranath KA; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):436-8. PubMed ID: 3198297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.